Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations

Bryna Harwood, Leslie A. Meyn, Susan A. Ballagh, Elizabeth G. Raymond, David F. Archer, Mitchell D Creinin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population. Study Design: This was an ancillary study of a trial comparing the efficacy of 5 nonoxynol-9 spermicides. A cohort of women who used condoms without spermicide served as a control group. Colposcopic examinations were performed during product use to identify genital lesions. Results: One hundred fifty-one participants had 1 or more follow-up examinations. At baseline, study groups differed only by the prevalence of baseline lesions. New lesions were identified at 49% of follow-up visits. Controlling for the presence of a baseline lesion, compared with condom use none of the spermicides were associated with an increase in new lesions (overall odds ratio, 0.8; 95% CI, 0.4-1.6; P = .5); and lesions characterized by epithelial disruption were less frequent with spermicide use (overall odds ratio, 0.3; 95% CI, 0.1-0.6; P < .001). Conclusion: In a low-risk population, women who used nonoxynol-9 spermicides were less likely to have lesions with epithelial disruption, and equally likely to have any new lesion compared with condom use.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume198
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Spermatocidal Agents
Nonoxynol
Condoms
Odds Ratio
Population
Epithelium
Control Groups

Keywords

  • colposcopy
  • epithelial disruption
  • nonoxynol-9
  • vaginal spermicides

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations. / Harwood, Bryna; Meyn, Leslie A.; Ballagh, Susan A.; Raymond, Elizabeth G.; Archer, David F.; Creinin, Mitchell D.

In: American Journal of Obstetrics and Gynecology, Vol. 198, No. 1, 01.2008.

Research output: Contribution to journalArticle

Harwood, Bryna ; Meyn, Leslie A. ; Ballagh, Susan A. ; Raymond, Elizabeth G. ; Archer, David F. ; Creinin, Mitchell D. / Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations. In: American Journal of Obstetrics and Gynecology. 2008 ; Vol. 198, No. 1.
@article{7627d13d652548b3b4bf7bceddecf7dc,
title = "Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations",
abstract = "Objective: This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population. Study Design: This was an ancillary study of a trial comparing the efficacy of 5 nonoxynol-9 spermicides. A cohort of women who used condoms without spermicide served as a control group. Colposcopic examinations were performed during product use to identify genital lesions. Results: One hundred fifty-one participants had 1 or more follow-up examinations. At baseline, study groups differed only by the prevalence of baseline lesions. New lesions were identified at 49{\%} of follow-up visits. Controlling for the presence of a baseline lesion, compared with condom use none of the spermicides were associated with an increase in new lesions (overall odds ratio, 0.8; 95{\%} CI, 0.4-1.6; P = .5); and lesions characterized by epithelial disruption were less frequent with spermicide use (overall odds ratio, 0.3; 95{\%} CI, 0.1-0.6; P < .001). Conclusion: In a low-risk population, women who used nonoxynol-9 spermicides were less likely to have lesions with epithelial disruption, and equally likely to have any new lesion compared with condom use.",
keywords = "colposcopy, epithelial disruption, nonoxynol-9, vaginal spermicides",
author = "Bryna Harwood and Meyn, {Leslie A.} and Ballagh, {Susan A.} and Raymond, {Elizabeth G.} and Archer, {David F.} and Creinin, {Mitchell D}",
year = "2008",
month = "1",
doi = "10.1016/j.ajog.2007.05.020",
language = "English (US)",
volume = "198",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations

AU - Harwood, Bryna

AU - Meyn, Leslie A.

AU - Ballagh, Susan A.

AU - Raymond, Elizabeth G.

AU - Archer, David F.

AU - Creinin, Mitchell D

PY - 2008/1

Y1 - 2008/1

N2 - Objective: This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population. Study Design: This was an ancillary study of a trial comparing the efficacy of 5 nonoxynol-9 spermicides. A cohort of women who used condoms without spermicide served as a control group. Colposcopic examinations were performed during product use to identify genital lesions. Results: One hundred fifty-one participants had 1 or more follow-up examinations. At baseline, study groups differed only by the prevalence of baseline lesions. New lesions were identified at 49% of follow-up visits. Controlling for the presence of a baseline lesion, compared with condom use none of the spermicides were associated with an increase in new lesions (overall odds ratio, 0.8; 95% CI, 0.4-1.6; P = .5); and lesions characterized by epithelial disruption were less frequent with spermicide use (overall odds ratio, 0.3; 95% CI, 0.1-0.6; P < .001). Conclusion: In a low-risk population, women who used nonoxynol-9 spermicides were less likely to have lesions with epithelial disruption, and equally likely to have any new lesion compared with condom use.

AB - Objective: This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population. Study Design: This was an ancillary study of a trial comparing the efficacy of 5 nonoxynol-9 spermicides. A cohort of women who used condoms without spermicide served as a control group. Colposcopic examinations were performed during product use to identify genital lesions. Results: One hundred fifty-one participants had 1 or more follow-up examinations. At baseline, study groups differed only by the prevalence of baseline lesions. New lesions were identified at 49% of follow-up visits. Controlling for the presence of a baseline lesion, compared with condom use none of the spermicides were associated with an increase in new lesions (overall odds ratio, 0.8; 95% CI, 0.4-1.6; P = .5); and lesions characterized by epithelial disruption were less frequent with spermicide use (overall odds ratio, 0.3; 95% CI, 0.1-0.6; P < .001). Conclusion: In a low-risk population, women who used nonoxynol-9 spermicides were less likely to have lesions with epithelial disruption, and equally likely to have any new lesion compared with condom use.

KW - colposcopy

KW - epithelial disruption

KW - nonoxynol-9

KW - vaginal spermicides

UR - http://www.scopus.com/inward/record.url?scp=37349113368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349113368&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2007.05.020

DO - 10.1016/j.ajog.2007.05.020

M3 - Article

C2 - 18166301

AN - SCOPUS:37349113368

VL - 198

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -